ArticleImmunoTargets and therapy2025

Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer Treatment.

Ilona Hagelstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.